- Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Emily Y. Yang et al, 2020, Frontiers in Oncology CrossRef - A CTLA-4 blocking strategy based on Nanobody in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects
Wu Wang et al, 2021, BMC Cancer CrossRef - Nanobodies in cell-mediated immunotherapy: On the road to fight cancer
Amirhosein Maali et al, 2023, Frontiers in Immunology CrossRef - Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies
Sayda Dhaouadi et al, 2021, Frontiers in Immunology CrossRef - A novel anti-CTLA-4 nanobody-IL12 fusion protein in combination with a dendritic cell/tumour fusion cell vaccine enhances the antitumour activity of CD8+ T cells in solid tumours
Meng-jie Jiang et al, 2024, Journal of Nanobiotechnology CrossRef - Fusing a Novel Anti-CTLA-4 Nanobody to the IgG1 Fc Region Strengthens Its Ability to Induce CD8+ T Cell-Mediated Immune Responses Against Solid Tumors
Ting-ting Li et al, 2024, International Journal of Nanomedicine CrossRef